Asthma is one of the most prevalent respiratory diseases in the world, and several of the variables associated with the illness may increase the susceptibility to psychiatric illnesses. This study was conducted to assess the prevalence of various psychiatric co-morbidities in the bronchial asthma patients. Methodology: It is an observational study conducted in 90 patients of bronchial asthma. Psychiatric co‐morbidities are assessed by using a pre‐designed short‐structured questionnaire with a component of Mini international neuropsychiatric interview. Results: The male predominant study showed an overall prevalence of 74.4% of psychiatric comorbidities in the bronchial asthma patients. The most prevalent comorbidities seen in this study were major depressive disorder (61%), panic disorder (50%), followed by melancholic depression (30%), mixed anxiety disorder (30%), premenstrual dysphoria (25.5%). Conclusion: Our study shows there is a high prevalence of psychiatric co‐morbidities in patients of bronchial asthma. The treatment of asthma should be a multidisciplinary approach including medical treatment of asthma and psychiatric evaluation to prevent psychiatric co‐morbidity or its early management